Recent developments in the design of bioreductive drugs

Br J Cancer Suppl. 1996 Jul:27:S32-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Biotransformation
  • Drug Design
  • Humans
  • Oxidation-Reduction
  • Prodrugs / metabolism
  • Topoisomerase II Inhibitors

Substances

  • Antineoplastic Agents
  • Prodrugs
  • Topoisomerase II Inhibitors